Jin-Qiu Yuan1, Yue-Bin Lv2, Hua-Shuai Chen3, Xiang Gao4, Zhao-Xue Yin5, Wen-Tao Wang2, Virginia Byers Kraus5, Jie-Si Luo6, Jiao-Nan Wang2, Yi Zeng7, Chen Mao8, Xiao-Ming Shi9. 1. Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, China. 2. National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing, China. 3. Center for the Study of Aging and Human Development and the Geriatric Division of School of Medicine, Duke University, Durham, NC. 4. Nutritional Epidemiology Lab, Pennsylvania State University, Philadelphia, PA. 5. Duke Molecular Physiology Institute and Division of Rheumatology, Department of Medicine, Duke University School of Medicine, Durham, NC. 6. Division of Non-Communicable Disease Control and Community Health, Chinese Center for Disease Control and Prevention, Beijing, China. 7. Center for the Study of Aging and Human Development and the Geriatric Division of School of Medicine, Duke University, Durham, NC; Center for Study of Healthy Aging and Development Studies, Peking University, Beijing, China. 8. Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, China. Electronic address: maochen9@smu.edu.cn. 9. National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing, China. Electronic address: shixm@chinacdc.cn.
Abstract
OBJECTIVES: To investigate the association between late-life blood pressure and the incidence of cognitive impairment in older adults. DESIGN: Prospective cohort study. SETTING: Community-living older adults from 22 provinces in China. PARTICIPANTS: We included 12,281 cognitively normal [Mini-Mental State Examination (MMSE) ≥ 24] older adults (median age: 81 years) from the Chinese Longitudinal Healthy Longevity Survey. Eligible participants must have baseline blood pressure data and have 1 or more follow-up cognitive assessments. MEASUREMENTS: Baseline systolic (SBP) and diastolic blood pressure (DBP) were measured by trained internists. Cognitive function was evaluated by MMSE. We considered mild/moderate/severe cognitive impairment (MMSE <24, and MMSE decline ≥3) as the primary outcome. RESULTS: The participants with hypertension had a significantly higher risk of mild/moderate/severe cognitive impairment (hazard ratio [HR] 1.17, 95% confidence interval [CI] 1.10-1.24). Overall, the associations with cognitive impairment seem to be hockey stick-shaped for SBP and linear for DBP, though the estimated effects for low SBP/DBP were less precise. High SBP was associated with a gradual increase in the risk of mild/moderate/severe cognitive impairment (P trend < .001). Compared with SBP 120 to 129 mmHg, the adjusted HR was 1.17 (95% CI 1.07-1.29) for SBP 130 to 139 mmHg, increased to 1.54 (95% CI 1.35-1.75) for SBP ≥180 mmHg. Analyses for high DBP showed the same increasing pattern, with an adjusted HR of 1.09 (95% CI 1.01-1.18) for DBP 90 to 99 mmHg and 1.19 (95% CI 1.02-1.38) for DBP ≥110 mmHg, as compared with DBP 70 to 79 mmHg. CONCLUSION: Late-life high blood pressure was independently associated with cognitive impairment in cognitively normal Chinese older adults. Prevention and management of high blood pressure may have substantial benefits for cognition among older adults in view of the high prevalence of hypertension in this rapidly growing population.
OBJECTIVES: To investigate the association between late-life blood pressure and the incidence of cognitive impairment in older adults. DESIGN: Prospective cohort study. SETTING: Community-living older adults from 22 provinces in China. PARTICIPANTS: We included 12,281 cognitively normal [Mini-Mental State Examination (MMSE) ≥ 24] older adults (median age: 81 years) from the Chinese Longitudinal Healthy Longevity Survey. Eligible participants must have baseline blood pressure data and have 1 or more follow-up cognitive assessments. MEASUREMENTS: Baseline systolic (SBP) and diastolic blood pressure (DBP) were measured by trained internists. Cognitive function was evaluated by MMSE. We considered mild/moderate/severe cognitive impairment (MMSE <24, and MMSE decline ≥3) as the primary outcome. RESULTS: The participants with hypertension had a significantly higher risk of mild/moderate/severe cognitive impairment (hazard ratio [HR] 1.17, 95% confidence interval [CI] 1.10-1.24). Overall, the associations with cognitive impairment seem to be hockey stick-shaped for SBP and linear for DBP, though the estimated effects for low SBP/DBP were less precise. High SBP was associated with a gradual increase in the risk of mild/moderate/severe cognitive impairment (P trend < .001). Compared with SBP 120 to 129 mmHg, the adjusted HR was 1.17 (95% CI 1.07-1.29) for SBP 130 to 139 mmHg, increased to 1.54 (95% CI 1.35-1.75) for SBP ≥180 mmHg. Analyses for high DBP showed the same increasing pattern, with an adjusted HR of 1.09 (95% CI 1.01-1.18) for DBP 90 to 99 mmHg and 1.19 (95% CI 1.02-1.38) for DBP ≥110 mmHg, as compared with DBP 70 to 79 mmHg. CONCLUSION: Late-life high blood pressure was independently associated with cognitive impairment in cognitively normal Chinese older adults. Prevention and management of high blood pressure may have substantial benefits for cognition among older adults in view of the high prevalence of hypertension in this rapidly growing population.
Authors: F-E de Leeuw; J C de Groot; M Oudkerk; J C M Witteman; A Hofman; J van Gijn; M M B Breteler Journal: Brain Date: 2002-04 Impact factor: 13.501
Authors: Yue-Bin Lv; Peng-Fei Zhu; Zhao-Xue Yin; Virginia Byers Kraus; Diane Threapleton; Choy-Lye Chei; Melanie Sereny Brasher; Juan Zhang; Han-Zhu Qian; Chen Mao; David Bruce Matchar; Jie-Si Luo; Yi Zeng; Xiao-Ming Shi Journal: J Am Med Dir Assoc Date: 2017-02-01 Impact factor: 4.669
Authors: Arline D Bohannon; Gerda G Fillenbaum; Carl F Pieper; Joseph T Hanlon; Dan G Blazer Journal: J Am Geriatr Soc Date: 2002-03 Impact factor: 5.562
Authors: V Solfrizzi; F Panza; A M Colacicco; A D'Introno; C Capurso; F Torres; F Grigoletto; S Maggi; A Del Parigi; E M Reiman; R J Caselli; E Scafato; G Farchi; A Capurso Journal: Neurology Date: 2004-11-23 Impact factor: 9.910